ScienceDirect® Home Skip Main Navigation Links
You have guest access to ScienceDirect. Find out more.
 
Home
Browse
My Settings
Alerts
Help
 Quick Search
 Search tips (Opens new window)
    Clear all fields    
advertisementadvertisement
The Journal of Steroid Biochemistry and Molecular Biology
Volume 103, Issue 1, January 2007, Pages 84-89
 
Font Size: Decrease Font Size  Increase Font Size
 Abstract - selected
Article
Purchase PDF (360 K)

 
 
 
Related Articles in ScienceDirect
View More Related Articles
 
View Record in Scopus
 
doi:10.1016/j.jsbmb.2006.07.004    How to Cite or Link Using DOI (Opens New Window)
Copyright © 2006 Elsevier Ltd All rights reserved.

Differential effects of Vitamin D analogs on calcium transport

Masaki NakaneCorresponding Author Contact Information, a, E-mail The Corresponding Author, Junli Maa, Andrew E. Rosea, Mark A. Osinskia and J. Ruth Wu-Wonga

aAbbott Laboratories, Abbott Park, IL 60064, United States

Received 11 January 2006; 
accepted 3 July 2006. 
Available online 13 October 2006.

Purchase the full-text article



References and further reading may be available for this article. To view references and further reading you must purchase this article.

Abstract

It is well known that the efficiency of intestinal active calcium transport is regulated by the Vitamin D receptor pathway and Vitamin D analogs seem to exhibit differential effects on intestinal active calcium transport. To investigate the molecular basis for the difference among Vitamin D analogs, we tested three Vitamin D analogs: 1,25-dihydroxyvitamin D3, 19-nor-1,25-dihydroxyvitamin D2, and 1α-hydroxyvitamin D2 ex vivo and in vitro.

In 5/6 nephrectomized rat intestinal active calcium transport, 19-nor-1,25-dihydroxyvitamin D2 did not show a significant effects on intestinal active calcium transport at all the concentrations tested, while 1α-hydroxyvitamin D2 at 0.33 and 0.67 μg/kg and 1,25-dihydroxyvitamin D3 at 1 μg/kg significantly stimulated calcium transport.

In Caco-2 cells, 19-nor-1,25-dihydroxyvitamin D2 did not show a significant effect on calcium transport, while 1,25-dihydroxyvitamin D3 and 1,25-dihydroxyvitamin D2 (the active form of 1α-hydroxyvitamin D2) stimulated calcium transport by 934 and 501% at 0.1 μM, respectively.

1,25-Dihydroxyvitamin D2 potently induced the expression of CALB3 and TRPV6 mRNA with an EC50 of 0.3 and 1.0 nM, whereas 19-nor-1,25-dihydroxyvitamin D2 was 10-fold less potent than 1,25-dihydroxyvitamin D2 in inducing CALB3 and TRPV6 mRNA. The three Vitamin D analogs had no significant effect on the expression of PMCA1 mRNA. These Vitamin D analogs did not change the expression of Vitamin D receptor (VDR) up to 10 nM, but stimulated CYP24A1 expression in a dose-dependent manner with the potency in the order of 1,25-dihydroxyvitamin D3 > 1,25-dihydroxyvitamin D2 = 19-nor-1,25-dihydroxyvitamin D2.

These results suggest that the differential effect of Vitamin D analogs on stimulating intestinal and Caco-2 calcium transport may be in part due to its different effect on stimulating CALB3 and TRPV6 mRNA expression.

Keywords: Vitamin D analogs; Paricalcitol; Calcitriol; VDR; Secondary hyperparathyroidism; Intestinal calcium transport; Caco-2; CALB3; TRPV6

Abbreviations: 1,25-dihydroxyvitamin D3, calcitriol; 19-nor-1,25-dihydroxyvitamin D2, paricalcitol; 1α-hydroxyvitamin D2, doxercalciferol; 1,25-dihydroxyvitamin D2, 25-hydroxy-doxercalciferol; CALB3, calbindin 3, Vitamin D-dependent calcium-binding protein, CABP9K, CABP1, calbindin D9K; TRPV6, transient receptor potential cation channel subfamily V member 6, epitherial calcium channel 2 (ECAC2), calcium transporter 1 (CAT1); CYP24A1, 1,25-dihydroxyvitamin D3 24-hydroxylase

Article Outline

1. Introduction
2. Materials and methods
2.1. Materials
2.2. 5/6 nephrectomized rats
2.3. Measurement of gastrointestinal transport
2.4. Cell culture
2.5. Calcium transport in Caco-2 cells
2.6. Real-time reverse transcription-PCR
3. Results
4. Discussion
Acknowledgements
References





 
Home
Browse
My Settings
Alerts
Help
Elsevier.com (Opens new window)
About ScienceDirect  |  Contact Us  |  Information for Advertisers  |  Terms & Conditions  |  Privacy Policy
Copyright © 2008 Elsevier B.V. All rights reserved. ScienceDirect® is a registered trademark of Elsevier B.V.